Nootropics & Cognitive Health

The nicotine-free oral delivery format is gaining traction as a disruptive vector for nootropic and energy ingredients …

The clinical-stage biotech is advancing allosteric small molecule therapies — a mechanism drawing growing interest from…

The policy initiative signals growing institutional demand for research-backed brain health solutions — a tailwind for …

As honey-matrix delivery formats gain shelf space in the nootropic category, regulators and consumers alike are pressin…

Findings from the first decentralized, real-world HD chorea study surface patient- and caregiver-reported outcomes — a …

Yale and Osmind researchers bring peer-reviewed real-world data to the ketamine therapy debate, with implications for c…

Stay ahead of the industry